Tech & Gadgets

Altis Labs raises $25 million USD Series A to expand AI for cancer trials

27 sec read14 views0 listens

Altis Labs, a Toronto-based healthtech startup, has secured $25 million USD in Series A funding to expand its AI-powered platform, IPRO. This technology analyzes radiology scans to predict patient survival, offering drug developers a potentially more reliable and earlier indication of treatment effectiveness in cancer trials. The advancement is significant because it could accelerate drug development timelines and lead to more informed decisions about promising therapies.

Read the full article at BetaKit

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Ali NematiBlogUI.author_articles

BlogUI.view_profile

You Might Like

AI & Machine Learning5 hours ago29 sec read

Nobody conducts the lanterns

A team has found that complex, decentralized systems can function effectively without a traditional hierarchical manager or conductor. This approach, where agents operate with autonomy and share observations through subtle cues, is significant for AI...

Ali Nemati

AI & Machine Learning5 hours ago32 sec read

MikroTik RouterOS Flaws and the SOHO Router Attack Surface

Security agencies have confirmed active exploitation of vulnerabilities, CVE-2026-67279 and CVE-2026-86060, within MikroTik RouterOS, prompting CISA to add them to its catalog of known exploited vulnerabilities. This highlights the persistent risk po...

Ali Nemati

AI & Machine Learning5 hours ago33 sec read

ListingMic Offline: A 30-Second Voice Pitch Becomes a Marketplace Listing, With No Cloud Bill

A new tool called ListingMic Offline helps artisans and makers quickly generate listing drafts for online marketplaces. It uses a local, open-weight version of the Whisper model to transcribe a 30-second voice recording of a product description, extr...

Ali Nemati